Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

(2017) Richard G. Gray et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)

(2015) RONG HU et al.   Oncology Letters

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

(2014) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis

(2014) Mustafa Al-Mubarak et al.   PLoS One

Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague-Dawley Rats

(2014) Karen M. Schweikart et al.   TOXICOLOGIC PATHOLOGY

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

(2012) Christina Davies et al.   LANCET

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

The effect of tamoxifen on the genital tract

(2008) Sandra A. Polin   CANCER IMAGING